Aug 2026· Fish and Shellfish Immunology· pp.
111670
· 0 citations· 47 references
Medicine
TL;DR
It is indicated that EcSrc promotes NF-κB-associated antiviral responses against SGIV and an EcSrc-TRAF5 interaction potentially involved in teleost antiviral immunity is identified and identified.
Abstract
Src, a prototypical non-receptor tyrosine kinase and central signaling hub, is well documented to play complex, and even opposing, roles in mammalian viral infections-both restricting viral replication and being hijacked by viruses to facilitate their own life cycles. However, its role in aquatic viral infections remains largely unexplored. Here, we characterized a novel Src homolog from Epinephelus coioides, designated EcSrc, and investigated its function during Singapore grouper iridovirus (SGIV) infection. EcSrc exhibited high sequence conservation with vertebrate orthologs from mammals to teleosts. In healthy fish, EcSrc transcripts predominated in head kidney and spleen, but were markedly downregulated upon SGIV challenge. Under basal conditions, EcSrc displayed a diffuse cytoplasmic distribution without discernible organelle-specific enrichment; however, at late stages of infection, it also localized to the nucleus and virus assembly sites. Overexpression of EcSrc significantly suppressed SGIV replication, and treatment with a Src family kinase inhibitor (PP2) enhanced viral replication, together indicating that EcSrc functions as a host restriction factor. EcSrc activated NF κB signaling by promoting IκBα and p65 phosphorylation and facilitating p65 nuclear translocation, which in turn induced inflammatory cytokine gene transcription. Notably, EcSrc could interact with TRAF5, an interaction that has not been previously reported. While TRAF5 alone exerted a suppressive effect on NF-κB, EcSrc overexpression possibly counteracted this inhibition, suggesting that EcSrc may relieve the TRAF5-imposed restriction on NF-κB activation. Together, our findings indicate that EcSrc promotes NF-κB-associated antiviral responses against SGIV and identify an EcSrc-TRAF5 interaction potentially involved in teleost antiviral immunity.
This study reveals a post-translational mechanism by which enteroviruses evade host antiviral defenses, providing a rationale for therapeutic development against enteroviral diseases.
Mengran Yuan, Xiaorong Qiao, Hua Wang et al.· Virologica Sinica· 0 citations
A novel mechanism where CcFTR54 restricts SVCV replication via NBR1-dependent selective autophagic degradation of the viral P protein, thereby broadening the insights into finTRIM-mediated antiviral immunity in teleosts.
Hong-Xia Gao, Fei Wang, Yihan Wang et al.· Fish and Shellfish Immunolog...· 0 citations
The role of the TRAF6-Akt axis in the life cycle of oncogenic herpesviruses is highlighted and potential therapeutic targets for related diseases are suggested.
Zhen-Shan Liu, Qing-Yu Guo, Weili Wang et al.· PLoS Pathogens· 0 citations
It is demonstrated that the host deubiquitinase OTUB2 stabilizes the viral replication factor NSP8 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through a dual-track mechanism and identifies OTUB2 as a potential target for host-directed antiviral intervention.
These findings reveal a proviral strategy whereby PRV UL40 hijacks EphA2 to counteract an intrinsic Akt-dependent inhibitory pathway, and EphA2 S897 represents a potential therapeutic target for mitigating alphaherpesvirus immunopathology.
Yutong Tian, Hang Yin, Jia-Xiang Fu et al.· Veterinary Research· 0 citations
Investigation of a diverse panel of 16 SIV Vpr isolates shows that 13 out of 16 are capable of significantly activating DDR signaling compared to control infected cells, and hijacking of DDR responses to promote remodeling of the nuclear environment is a broadly conserved Vpr function.
Zaddock Williford, Emily Leavitt, Nicholas Saladino et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.